高级检索

宫颈液基细胞学检查联合高危型人乳头瘤病毒检测在宫颈癌筛查中的应用价值

周扬帆, 杨晓扬, 朱成全, 王爱武, 陈艳宇, 谭夕, 陈钰, 迮浩城, 刘艳红

周扬帆, 杨晓扬, 朱成全, 王爱武, 陈艳宇, 谭夕, 陈钰, 迮浩城, 刘艳红. 宫颈液基细胞学检查联合高危型人乳头瘤病毒检测在宫颈癌筛查中的应用价值[J]. 实用临床医药杂志, 2020, 24(15): 46-50,54. DOI: 10.7619/jcmp.202015013
引用本文: 周扬帆, 杨晓扬, 朱成全, 王爱武, 陈艳宇, 谭夕, 陈钰, 迮浩城, 刘艳红. 宫颈液基细胞学检查联合高危型人乳头瘤病毒检测在宫颈癌筛查中的应用价值[J]. 实用临床医药杂志, 2020, 24(15): 46-50,54. DOI: 10.7619/jcmp.202015013
shu
ZHOU Yangfan, YANG Xiaoyang, ZHU Chengquan, WANG Aiwu, CHEN Yanyu, TAN Xi, CHEN Yu, ZE Haocheng, LIU Yanhong. Value of thinprep cytologic test combined with detection of high-risk human papillomavirus in screening of cervical cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(15): 46-50,54. DOI: 10.7619/jcmp.202015013
Citation: ZHOU Yangfan, YANG Xiaoyang, ZHU Chengquan, WANG Aiwu, CHEN Yanyu, TAN Xi, CHEN Yu, ZE Haocheng, LIU Yanhong. Value of thinprep cytologic test combined with detection of high-risk human papillomavirus in screening of cervical cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(15): 46-50,54. DOI: 10.7619/jcmp.202015013
shu

宫颈液基细胞学检查联合高危型人乳头瘤病毒检测在宫颈癌筛查中的应用价值

  • 1. 广东省第二人民医院/广东省应急医院 病理科, 广东 广州, 510317;

  • 2. 中国人民解放军陆军第七十四集团军医院, 广东 广州, 510318;

  • 3. 广东省第二人民医院/广东省应急医院 妇科, 广东 广州, 510317

基金项目: 

广东省医学科学技术研究基金项目(B2017096)

详细信息

  • 中图分类号: R737.33

Value of thinprep cytologic test combined with detection of high-risk human papillomavirus in screening of cervical cancer

  • 1. Department of Pathology, Second People's Hospital of Guangdong Province, Emergency Hospital of Guangdong Province, Guangzhou, Guangdong, 510317;

  • 2. 74th Army Hospital of Land Force of People's Liberation Army, Guangzhou, Guangdong, 510318;

  • 3. Department of Gynaecology, Second People's Hospital of Guangdong Province, Emergency Hospital of Guangdong Province, Guangzhou, Guangdong, 510317

摘要

    摘要
  • 摘要: 目的 探讨宫颈液基细胞学检查(TCT)联合高危型人乳头瘤病毒(HR-HPV)核酸检测在宫颈癌筛查中的应用价值。 方法 回顾性分析332例经TCT诊断为意义不明确的非典型鳞状细胞(ASC-US)患者的HR-HPV核酸检测结果和组织病理检查结果,将ASC-US患者按不同年龄段分为青年组及中老年组,比较2组HR-HPV结果及宫颈组织病理检查结果。 结果 TCT(ASC-US)且HR-HPV(+)组的宫颈组织病理学符合率高于TCT(ASC-US)且HR-HPV(-)组、TCT(阴性)且HR-HPV(+)组,差异有统计学意义(P<0.001); 青年组的HR-HPV核酸阳性率、组织病理学阳性率与中老年组比较,差异有统计学意义(P<0.05); 2组ASC-US患者HR-HPV核酸检测的准确率、灵敏度及阳性预测值比较,差异无统计学意义(P>0.05), 但HR-HPV核酸检测的特异度、约登指数、阴性预测值比较,差异有统计学意义(P<0.05); 全组、青年组、中老年组患者中,不同级别宫颈病变的HR-HPV阳性率比较,差异均有统计学意义(P<0.05)。 结论 TCT诊断为ASC-US的患者联合采用HR-HPV检测可以提高宫颈鳞状上皮内病变的检出率,尤其适用于中老年人群。
    Abstract: Objective To analyze the application value of nucleic acid detection of thinprep cytologic test(TCT)combined with nucleic acid detection of high-risk human papillomavirus(HR-HPV)in screening of cervical cancer. Methods The results of nucleic acid of HR-HPV and histopathology test in 332 cases confirmed as atypical squamous cells of undetermined significance(ASC-US)by TCT were retrospectively analyzed. These confirmed patients were divided into young group and middle and higher aged group according to age. The results of HR-HPV and cervical histopathology were compared between the two groups. Results The patients confirmed as ASC-US by TCT combined with positive HR-HPV had significantly higher histopathological coincidence rate of than those confirmed as ASC-US by TC combined with negative HR-HPV and those without ASC-US combined with positive HR-HPV(P<0.001). The positive rates of HR-HPV nucleic acid and histopathology tests in the young group - showed significant differences compared to those of the middle and higher aged group(P<0.05). There were no significant differences in the accuracy, sensitivity and positive predictive value of nucleic acid test of HR-HPV in ASC-US patients of two groups(P>0.05), but there were significant between-group differences in the specificity, Jordan index and negative predictive value of HR-HPV nucleic acid test(P<0.05). There was significant difference in the HR-HPV positive rate of different levels of cervical lesions in the whole group, the young group or the middle and higher-aged group(P<0.05). Conclusion The combination of HR-HPV improves the detection rate of cervical squamous intraepithelial lesions in ASC-US patients confirmed by TCT, and it is especially suitable to middle and higher aged group.
    • HTML全文
    • 参考文献(22)
  • 顾秀英, 郑荣寿, 孙可欣, 等. 2014年中国女性子宫颈癌发病与死亡分析[J]. 中华肿瘤杂志, 2018, 40(4):241-246.

    SUNDSTRÖM K, LU D H, ELFSTRÖM K M, et al. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion:a nationwide cohort study[J]. Am J Obstet Gynecol, 2017, 216(1):48. e1-48. e15.

    NAYAR R, WILBUR D C. The Pap test and Bethesda 2014[J]. Cancer Cytopathol, 2015, 123(5):271-281.
    NAYAR R, WILBUR D C. 子宫颈细胞学Bethesda报告系统[M]. 陈小槐译. 第3版. 北京:科技出版社, 2018:27-225.

    KURMAN R J, CARCANGIU M L, HERRINGTON C S, et al. WHO classification of tumours of female reproductive organs[M]. Lyon:IARC Press, 2014:63-64.

    TAI Y J, CHEN Y Y, HSU H C, et al. Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management:a population-based cohort study[J]. J Gynecol Oncol, 2018, 29(4):e55-e64.

    CUELLO M A, ESPINOSA M E, ORLANDINI E J, et al. The value of endocervical curettage during loop electrosurgical excision procedures in predicting persistent/recurrent preinvasive cervical disease[J]. Int J Gynaecol Obstet, 2018, 141(3):337-343.

    EL-NASHAR S A, SHAZLY S A, HOPKINS M R, et al. Loop electrosurgical excision procedure instead of cold-knife conization for cervical intraepithelial neoplasia in women with unsatisfactory colposcopic examinations:a systematic review and meta-analysis[J]. J Low Genit Tract Dis, 2017, 21(2):129-136.

    DÍAZ DEL ARCO C, JIMÉNEZ AYALA B, GARCÍA D, et al. Distribution of cervical lesions in young and older women[J]. Diagn Cytopathol, 2019, 47(7):659-664.

    NOVIKOVA T. Optical techniques for cervical neoplasia detection[J]. Beilstein J Nanotechnol, 2017, 8:1844-1862.

    MASSAD L S, EINSTEIN M H, HUH W K, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors[J]. J Low Genit Tract Dis, 2013, 17:S1-S27.

    Società italiana di Colposcopia e Patologia Cervico vaginale. Gestione della paziente con pap test anormale linee guida edizione 2006[J]. La Colposcopia in Italia, 2006, 21(1):11-12.

    GOKSEDEF B P, AKBAYIR O, BARAN S Y, et al. Atypical squamous cells of undetermined significance in postmenopausal women:a comparative retrospective analysis[J]. Eur J Obstet Gynecol Reprod Biol, 2011, 159(2):418-421.
    张莉萍, 桂贤, 奚豪, 等. 宫颈液基薄层细胞学和组织病理学对照研究[J]. 同济大学学报:医学版, 2010, 31(3):50-54.

    DEMIRTAS G S, AKMAN L, DEMIRTAS O, et al. Clinical significance of ASCUS and ASC-H cytological abnormalities:a six-year experience at a single center[J]. Eur J Gynaecol Oncol, 2015, 36(2):150-154.
    谢幸, 苟文丽. 妇产科学[M]. 8版. 北京:人民卫生出版社, 2013:410-410.

    WANG Y Y, KONG L H, LIU Y, et al. Retrospective analysis of cervical cancer and precancerous lesions in patients with atypical squamous cells of undetermined significance in China[J]. Medicine(Baltimore), 2019, 98(49):e18239.

    FIRNHABER C, SWARTS A, GOEIEMAN B, et al. Cryotherapy reduces progression of cervical intraepithelial neoplasia grade 1 in south African HIV-infected women:a randomized, controlled trial[J]. J Acquir Immune Defic Syndr, 2017, 76(5):532-538.

    HAKEM E, IBRAHIM E, TANYOUS E, et al. Association between grade of referral smear and high-grade disease among women with biopsy samples showing cervical intraepithelial neoplasia grade 2[J]. Int J Gynaecol Obstet, 2018, 140(2):223-227.
    黄燕明, 王燕, 阳艳, 等. 宫颈细胞学正常的高危HPV感染妇女病理结局分析[J]. 现代妇产科进展, 2017, 26(2):143-144

    , 148.

    BRUNO M T, COCO A, DI PASQUA S, et al. Management of ASC-US/HPV positive post-menopausal woman[J]. Virol J, 2019, 16(1):39.
    效小莉, 付凤仙, 宋紫晖. 高危型HPV分型检测作为ASCUS分流管理手段的探讨[J]. 中国妇幼保健, 2019, 34(13):2946-2949.
    • 相关文章
    • 施引文献(15)

  • 期刊类型引用(15)

    1. 张田玲，孙晓琳，李庆. 高危人乳头状瘤病毒检测联合液基细胞学检查在早期宫颈病变筛查中的价值. 妇儿健康导刊. 2024(01): 124-126 . 百度学术
    2. 王侠，杨翠. 组合性抗体在分流ASC-US病变中的应用价值. 湖北科技学院学报(医学版). 2023(04): 303-306+312 . 百度学术
    3. 黄秋菊. TCT联合HPV检测和阴道镜检查在早期宫颈病变筛查中的价值分析. 黑龙江医药. 2023(05): 1186-1188 . 百度学术
    4. 杨敏，屈阿敏，王娟. TCT联合高危型HPV检查筛查妊娠期宫颈癌价值. 中国计划生育学杂志. 2023(11): 2688-2691+2697 . 百度学术
    5. 吴海乔，王文娟，胡君程. 探讨宫颈液基细胞学检查在子宫颈癌筛查中的作用. 黑龙江医药. 2023(06): 1402-1405 . 百度学术
    6. 解培风. TCT联合HPV-DNA检测在宫颈病变筛查中的应用. 实用妇科内分泌电子杂志. 2023(32): 119-121 . 百度学术
    7. 李正岩. 乳头瘤病毒检查在早期宫颈癌筛查中的应用分析. 中国现代药物应用. 2022(04): 105-108 . 百度学术
    8. 宋瑞红，陈英，高秀苹. 液基细胞学检测在宫颈癌筛查中的应用价值. 当代医学. 2022(18): 173-175 . 百度学术
    9. 孙培勇. 宫颈癌前病变患者在新柏氏液基细胞学检测诊断中出现假阴性的相关因素分析. 中国当代医药. 2022(23): 145-148+152 . 百度学术
    10. 杨婷婷，牛爱琴. TCT及HPV检测与阴道镜检查在宫颈癌前病变和宫颈癌筛查中的应用价值. 医药论坛杂志. 2022(21): 17-20 . 百度学术
    11. 高顺梅，李鑫瀛，马英. 高危型HPV检测联合TCT对宫颈癌前病变筛查的意义分析. 实用妇科内分泌电子杂志. 2022(21): 87-90 . 百度学术
    12. 王慧芳，侍孝远. 宫颈癌筛查技术对预防宫颈癌疾病的临床价值. 名医. 2022(20): 69-71 . 百度学术
    13. 毛康娜，刘艳欣，陶惠芬. 14398名妇女宫颈癌筛查结果分析. 河南医学研究. 2021(16): 2921-2923 . 百度学术
    14. 赵艳. 宫颈癌筛查系统（TS）联合人乳头瘤病毒（HPV）检测在宫颈癌筛查中的效果探究. 实用妇科内分泌电子杂志. 2021(34): 80-82 . 百度学术
    15. 刘庆云. 高危HPV检测联合液基薄层细胞检测在宫颈癌筛查中的应用. 中国误诊学杂志. 2020(11): 506-508 . 百度学术

    其他类型引用(0)

    • 资源附件(0)
计量
  • 文章访问数:  307
  • HTML全文浏览量:  55
  • PDF下载量:  21
  • 被引次数: 15
出版历程
  • 收稿日期:  2020-06-22
  • 发布日期:  2020-09-09

目录

摘要
HTML全文
    参考文献(22)
    相关文章
    施引文献(15)
    资源附件(0)

    /

    返回文章
    返回

    © 2020 《实用临床医药杂志》编辑部

    地址：江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室邮编：225009电话：0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    本系统由 北京仁和汇智信息技术有限公司 开发  百度统计

    x 关闭 永久关闭